Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea.
PLoS One. 2018 Aug 29;13(8):e0202872. doi: 10.1371/journal.pone.0202872. eCollection 2018.
Hemi-ablation of prostate cancer (PCa) requires an accurate prediction of laterality. Recently, multi-parametric magnetic resonance imaging (mpMRI) has recently been increasingly used to enhance clinical staging and characterization of tumor foci. Thus, we tried to investigate the real-life accuracy of combinatory approach of using both transrectal ultrasound (TRUS)-guided prostatic biopsy and mpMRI in predicting the laterality of PCa. We reviewed the records of 335 men who were suspected of having unilateral PCa on multi (≥ 12)-core TRUS-guided biopsy and preoperative mpMRI and subsequently had undergone radical prostatectomy (RP) at our institution. Based on the analysis of pathologic outcomes from RP, the performance of the combinatory approach in predicting the pathological laterality of PCa was evaluated. Pathology was classified to be unfavorable when showing a Gleason pattern of 4/5 or pT3/N1 features. Significant cancer was defined as non-organ-confined disease, having a Gleason pattern of 4/5, or showing a cancer volume of ≥ 0.5 mL. Among the 335 unilateral lobes not suspected to harbor tumor from either the TRUS biopsy or mpMRI, the actual absence rate of malignancy was only 13.7% from a pathologic analysis of RP specimens. Even among the 115 D'Amico low-risk group, the absence rate of malignancy was only 26.1% in unilateral lobes not suspected to harbor tumor. Among the 335 lobes, unfavorable pathology and significant cancer were not observed in 36.1% and 30.7%, respectively. The absence rates of unfavorable pathology and significant cancer among the D'Amico low risk group were 56.5% and 47.8%, respectively. Meanwhile, the absence rate of dominant Gleason pattern 4 or 5 was 74.9% among the 335 total subjects. Our real-life clinical experience showed that the combination of multi-core TRUS-guided biopsy and mpMRI did not provide reliable accuracy in the prediction of true unilaterality of PCa.
前列腺癌(PCa)的半侧切除术需要准确预测肿瘤的侧别。最近,多参数磁共振成像(mpMRI)已被越来越多地用于增强肿瘤病灶的临床分期和特征描述。因此,我们尝试研究使用经直肠超声(TRUS)引导的前列腺活检和 mpMRI 联合方法预测 PCa 侧别的真实临床准确性。我们回顾了 335 名在多(≥12 针)针 TRUS 引导的前列腺活检和术前 mpMRI 中被怀疑单侧 PCa 的男性患者的记录,随后在我们机构接受了根治性前列腺切除术(RP)。根据 RP 病理结果分析,评估了联合方法预测 PCa 病理侧别的性能。当病理结果显示格里森评分 4/5 或 pT3/N1 特征时,将其归类为不利。显著癌症定义为非器官受限疾病,格里森评分 4/5,或癌症体积≥0.5ml。在 335 个单侧叶中,无论是 TRUS 活检还是 mpMRI 均未怀疑有肿瘤存在,从 RP 标本的病理分析来看,恶性肿瘤的实际无瘤率仅为 13.7%。即使在 115 名 D'Amico 低危组中,单侧叶无肿瘤的无瘤率也仅为 26.1%。在 335 个叶中,不利病理和显著癌症的发生率分别为 36.1%和 30.7%。D'Amico 低危组中无不利病理和显著癌症的发生率分别为 56.5%和 47.8%。同时,335 名患者中,主要格里森评分 4 或 5 的无瘤率为 74.9%。我们的临床经验表明,多针 TRUS 引导的前列腺活检和 mpMRI 联合并不能可靠地预测 PCa 的真正单侧性。